Literature DB >> 23359503

Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined.

Sandra E Dillahunt1, Jennifer L Sargent, Ryo Suzuki, Richard L Proia, Alasdair Gilfillan, Juan Rivera, Ana Olivera.   

Abstract

FcεRI engagement in mast cells (MCs) induces the activation of two distinct sphingosine kinase isoforms (SphK1 and SphK2) to produce sphingosine-1-phosphate, a mediator essential for MC responses. Whereas embryonic-derived SphK2-null MCs showed impaired responses to Ag, RNA silencing studies on other MC types indicated a dominant role for SphK1. Given the known functional heterogeneity of MCs, we explored whether the reported differences in SphK1 or SphK2 usage could be reflective of phenotypic differences between MC populations. Using lentiviral-based short hairpin RNA to silence SphK1 or SphK2, we found that SphK2 is required for murine MC degranulation, calcium mobilization, and cytokine and leukotriene production, irrespective of the tissue from which the MC progenitors were derived, the stage of MC granule maturity, or the conditions used for differentiation. This finding was consistent with the lack of a full allergic response in SphK2-null mice challenged to undergo passive cutaneous anaphylaxis. A redundant role for both SphKs was uncovered, however, in chemotaxis toward Ag in all MC types tested and in TNF-α production in certain MC types. In contrast, human MC responses were dependent only on SphK1, associating with a more robust expression of this isoform and a more varied representation of SphK variants relative to murine MCs. The findings show that the function of SphK1 and SphK2 can be interchangeable in MCs; however, an important determinant of SphK isoform usage is the species of origin and an influencing factor, the tissue from which MCs may be derived and/or their differentiation state.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23359503      PMCID: PMC3577945          DOI: 10.4049/jimmunol.1201503

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  Loss of TRPC1-mediated Ca2+ influx contributes to impaired degranulation in Fyn-deficient mouse bone marrow-derived mast cells.

Authors:  Ryo Suzuki; Xibao Liu; Ana Olivera; Lizath Aguiniga; Yumi Yamashita; Ulrich Blank; Indu Ambudkar; Juan Rivera
Journal:  J Leukoc Biol       Date:  2010-06-22       Impact factor: 4.962

Review 2.  Regulation of sphingosine kinase and sphingolipid signaling.

Authors:  Stuart M Pitson
Journal:  Trends Biochem Sci       Date:  2010-10-01       Impact factor: 13.807

3.  Measuring mast cell mediator release.

Authors:  Hye Sun Kuehn; Madeleine Radinger; Alasdair M Gilfillan
Journal:  Curr Protoc Immunol       Date:  2010-11

4.  Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood.

Authors:  Madeleine Rådinger; Bettina M Jensen; Hye Sun Kuehn; Arnold Kirshenbaum; Alasdair M Gilfillan
Journal:  Curr Protoc Immunol       Date:  2010-08

5.  Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice.

Authors:  Ana Olivera; Christoph Eisner; Yoshiaki Kitamura; Sandra Dillahunt; Laura Allende; Galina Tuymetova; Wendy Watford; Francoise Meylan; Susanne C Diesner; Lingli Li; Jurgen Schnermann; Richard L Proia; Juan Rivera
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

Review 6.  Sphingosine 1-phosphate and cancer.

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Nat Rev Cancer       Date:  2010-06-17       Impact factor: 60.716

Review 7.  Fingolimod is a potential novel therapy for multiple sclerosis.

Authors:  Orhan Aktas; Patrick Küry; Bernd Kieseier; Hans-Peter Hartung
Journal:  Nat Rev Neurol       Date:  2010-06-15       Impact factor: 42.937

Review 8.  The outs and the ins of sphingosine-1-phosphate in immunity.

Authors:  Sarah Spiegel; Sheldon Milstien
Journal:  Nat Rev Immunol       Date:  2011-05-06       Impact factor: 53.106

9.  Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice.

Authors:  Eric Camerer; Jean B Regard; Ivo Cornelissen; Yoga Srinivasan; Daniel N Duong; Daniel Palmer; Trung H Pham; Jinny S Wong; Rajita Pappu; Shaun R Coughlin
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

10.  Sphingosine kinase 1 localized to the plasma membrane lipid raft microdomain overcomes serum deprivation induced growth inhibition.

Authors:  Jeremy A Hengst; Jacquelyn M Guilford; Todd E Fox; Xujun Wang; Elizabeth J Conroy; Jong K Yun
Journal:  Arch Biochem Biophys       Date:  2009-09-24       Impact factor: 4.013

View more
  10 in total

Review 1.  Signal transduction and chemotaxis in mast cells.

Authors:  Petr Draber; Ivana Halova; Iva Polakovicova; Toshiaki Kawakami
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

Review 2.  Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function.

Authors:  Joseph M Kulinski; Rosa Muñoz-Cano; Ana Olivera
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

3.  Sphingosine-1-phosphate can promote mast cell hyper-reactivity through regulation of contactin-4 expression.

Authors:  Ana Olivera; Yoshiaki Kitamura; Laurel D Wright; Maria L Allende; Weiping Chen; Tomomi Kaneko-Goto; Yoshihiro Yoshihara; Richard L Proia; Juan Rivera
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

Review 4.  Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.

Authors:  Eric Schauberger; Miriam Peinhaupt; Tareian Cazares; Andrew W Lindsley
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 5.  Mast Cell-Biomaterial Interactions and Tissue Repair.

Authors:  Emily W Ozpinar; Ariana L Frey; Glenn Cruse; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2021-01-21       Impact factor: 6.389

Review 6.  Role of Sphingosine-1-Phosphate in Mast Cell Functions and Asthma and Its Regulation by Non-Coding RNA.

Authors:  Rohit Saluja; Ashok Kumar; Manju Jain; Sudhir K Goel; Aklank Jain
Journal:  Front Immunol       Date:  2017-05-22       Impact factor: 7.561

7.  ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling.

Authors:  Viktor Bugajev; Ivana Halova; Livia Demkova; Sara Cernohouzova; Petra Vavrova; Michal Mrkacek; Pavol Utekal; Lubica Draberova; Ladislav Kuchar; Björn Schuster; Petr Draber
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

Review 8.  Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface.

Authors:  Kana Masuda-Kuroki; Anna Di Nardo
Journal:  Biology (Basel)       Date:  2022-05-25

9.  Dermal Extracellular Matrix-Derived Hydrogels as an In Vitro Substrate to Study Mast Cell Maturation.

Authors:  Emily W Ozpinar; Ariana L Frey; Greer K Arthur; Camilo Mora-Navarro; Andreea Biehl; Douglas B Snider; Glenn Cruse; Donald O Freytes
Journal:  Tissue Eng Part A       Date:  2020-11-19       Impact factor: 4.080

10.  Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.

Authors:  Geethani Bandara; Rosa Muñoz-Cano; Araceli Tobío; Yuzhi Yin; Hirsh D Komarow; Avanti Desai; Dean D Metcalfe; Ana Olivera
Journal:  Front Immunol       Date:  2018-03-28       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.